Related references
Note: Only part of the references are listed.ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria
Gema Ariceta et al.
PEDIATRIC NEPHROLOGY (2023)
Probiotics and their Metabolites Reduce Oxidative Stress in Middle-Aged Mice
Wen-Yang Lin et al.
CURRENT MICROBIOLOGY (2022)
Protective Effect of Gamma Aminobutyric Acid against Aggravation of Renal Injury Caused by High Salt Intake in Cisplatin-Induced Nephrotoxicity
Hyesook Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
Vadim Pivniouk et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Estimated Glomerular Filtration Rate in Chronic Kidney Disease: A Critical Review of Estimate-Based Predictions of Individual Outcomes in Kidney Disease
Lajos Zsom et al.
TOXINS (2022)
Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition
A. Verhulst et al.
UROLITHIASIS (2022)
Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review
Nathalie Demoulin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2022)
Oxalobacter formigenes: A new hope as a live biotherapeutic agent in the management of calcium oxalate renal stones
Shridhar Hiremath et al.
ANAEROBE (2022)
New therapeutics for primary hyperoxaluria type 1
Pegah Dejban et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2022)
RICORS2040: the need for collaborative research in chronic kidney disease
Alberto Ortiz
CLINICAL KIDNEY JOURNAL (2022)
Treatment of primary hyperoxaluria type 1
Asheeta Gupta et al.
CLINICAL KIDNEY JOURNAL (2022)
Primary hyperoxaluria type 1: time for prime time?
Justine Bacchetta et al.
CLINICAL KIDNEY JOURNAL (2022)
Gut Microbiome and Kidney Disease Reconciling Optimism and Skepticism
Divya Shankaranarayanan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)
Pathophysiology and Treatment of Enteric Hyperoxaluria
Celeste Witting et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study
Bernd Hoppe et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Gamma-aminobutyric acid-salt attenuated high cholesterol/high salt diet induced hypertension in mice
Myeongjoo Son et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2021)
Lipolytic Postbiotic from Lactobacillus paracasei Manages Metabolic Syndrome in Albino Wistar Rats
Ali Osman et al.
MOLECULES (2021)
Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review
Jin Zhao et al.
RENAL FAILURE (2021)
Postbiotics, Metabolic Signaling, and Cancer
Nikola Vrzackova et al.
MOLECULES (2021)
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
Seppo Salminen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Phosphate, Microbiota and CKD
Chiara Favero et al.
NUTRIENTS (2021)
Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease
Menghan Liu et al.
ELIFE (2021)
The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease
Mingxuan Chi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Effect of Postbiotic Based on Lactic Acid Bacteria on Semen Quality and Health of Male Rabbits
Jesus V. Diaz Cano et al.
ANIMALS (2021)
Extracellular Vesicle Analysis by Paper Spray Ionization Mass Spectrometry
Casey A. Chamberlain et al.
METABOLITES (2021)
Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist
Steven L. Daniel et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2021)
Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trial
Dakota Rhys-Jones et al.
TRIALS (2021)
Effect of antibiotic treatment on Oxalobacter formigenes colonization of the gut microbiome and urinary oxalate excretion
Lama Nazzal et al.
SCIENTIFIC REPORTS (2021)
Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6
Marguerite Hatch
UROLITHIASIS (2020)
Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis
Lars Pape et al.
PEDIATRIC NEPHROLOGY (2020)
Skin Cutibacterium acnes Mediates Fermentation to Suppress the Calcium Phosphate-Induced Itching: A Butyric Acid Derivative with Potential for Uremic Pruritus
Sunita Keshari et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial
Viola Andresen et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Oxalobacter formigenes produces metabolites and lipids undetectable in oxalotrophic Bifidobacterium animalis
Casey A. Chamberlain et al.
METABOLOMICS (2020)
Microbial Peer Pressure The Role of the Gut Microbiota in Hypertension and Its Complications
Rikeish R. Muralitharan et al.
HYPERTENSION (2020)
Association of trimethylamineN-Oxide with cardiovascular and all-cause mortality in hemodialysis patients
Pan Zhang et al.
RENAL FAILURE (2020)
Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis
Aaron W. Miller et al.
KIDNEY INTERNATIONAL (2019)
Precision Nutrition and the Microbiome, Part I: Current State of the Science
Susan Mills et al.
NUTRIENTS (2019)
The use of antibiotics and risk of kidney stones
Shivam Joshi et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2019)
The Effect of 2 Weeks of Inactivated Probiotic Bacillus coagulans on Endocrine, Inflammatory, and Performance Responses During Self-Defense Training in Soldiers
Jay R. Hoffman et al.
JOURNAL OF STRENGTH AND CONDITIONING RESEARCH (2019)
Role of Probiotics in Human Gut Microbiome-Associated Diseases
Seon-Kyun Kim et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Health Benefits of Lactobacillus gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study
Kensei Nishida et al.
NUTRIENTS (2019)
Lyso-Gb3 modulates the gut microbiota and decreases butyrate production
John-Jairo Aguilera-Correa et al.
SCIENTIFIC REPORTS (2019)
A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria
Dawn Milliner et al.
UROLITHIASIS (2018)
Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers
Andrea Ticinesi et al.
GUT (2018)
Extensive impact of non-antibiotic drugs on human gut bacteria
Lisa Maier et al.
NATURE (2018)
Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells
Donna Arvans et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man
Jonathan M. Whittamore et al.
UROLITHIASIS (2017)
Gut microbiota in chronic kidney disease
Secundino Cigarran Guldris et al.
NEFROLOGIA (2017)
Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity
Eva Montane et al.
PLOS ONE (2017)
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
Paulina Markowiak et al.
NUTRIENTS (2017)
Preventive Effect of Cow's Milk Fermented with Lactobacillus paracasei CBA L74 on Common Infectious Diseases in Children: A Multicenter Randomized Controlled Trial
Giovanni Corsello et al.
NUTRIENTS (2017)
Cow's milk and rice fermented with Lactobacillus paracasei CBA L74 prevent infectious diseases in children: A randomized controlled trial
Rita Nocerino et al.
CLINICAL NUTRITION (2017)
Dietary fiber and prebiotics and the gastrointestinal microbiota
Hannah D. Holscher
GUT MICROBES (2017)
Holes in the Hologenome: Why Host-Microbe Symbioses Are Not Holobionts
Angela E. Douglas et al.
mBio (2016)
Fermented infant formulas without live bacteria: a systematic review
Hania Szajewska et al.
EUROPEAN JOURNAL OF PEDIATRICS (2015)
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation)
Fulvio Braido et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
Effectiveness of Polyvalent Bacterial Lysate and Autovaccines Against Upper Respiratory Tract Bacterial Colonization by Potential Pathogens: A Randomized Study
Olaf Zagolski et al.
MEDICAL SCIENCE MONITOR (2015)
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: The results of a double blind, placebo controlled, multicenter clinical trial
Fulvio Braido et al.
IMMUNOLOGY LETTERS (2014)
p-Cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells
Jonay Poveda et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v
Claire Jones et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Therapeutic effects of inhaled inactivated Mycobacterium phlei in adult patients with moderate persistent asthma
Jinghong Zhang et al.
IMMUNOTHERAPY (2012)
Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
Tatiana Takiishi et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation
Chiao-Yin Sun et al.
KIDNEY INTERNATIONAL (2012)
The Effect of Inactivated Lactobacillus LB Fermented Culture Medium on Symptom Severity: Observational Investigation in 297 Patients with Diarrhea-Predominant Irritable Bowel Syndrome
A. L. Tarrerias et al.
DIGESTIVE DISEASES (2011)
A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy
M. Morisset et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2011)
Hyperoxaluria: a gut-kidney axis?
Stef Robijn et al.
KIDNEY INTERNATIONAL (2011)
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria
Bernd Hoppe et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Oral Immunotherapy With Inactivated Nontypeable Haemophilus influenzae Reduces Severity of Acute Exacerbations in Severe COPD
Maharaj Kishore Tandon et al.
CHEST (2010)
An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea
Vanessa Lievin-Le Moal et al.
PEDIATRICS (2007)
Effect of a fermented formula on thymus size and stool pH in healthy term infants
Flavia Indrio et al.
PEDIATRIC RESEARCH (2007)
Effectiveness and safety of lactobacillus LB in the treatment of mild acute diarrhea in children
Eduardo Salazar-Lindo et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Micronutrients (including zinc) reduce diarrhoea in children: The Pakistan sprinkles diarrhoea study
W. Sharieff et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2006)
Oxalobacter sp reduces urinary oxalate excretion by promoting enteric oxalate secretion
M Hatch et al.
KIDNEY INTERNATIONAL (2006)
The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite
GC Peng et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2005)
Effect of a γ-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats
K Hayakawa et al.
BRITISH JOURNAL OF NUTRITION (2004)
Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants
H Thibault et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Benefits of a thickened infant formula with lactase activity in the management of benign digestive disorders in newborns
P Roy et al.
ARCHIVES DE PEDIATRIE (2004)
Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants:: A randomized, double-blind, placebo-controlled trial
C Mullié et al.
PEDIATRIC RESEARCH (2004)
Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea
SD Xiao et al.
ADVANCES IN THERAPY (2003)
Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives
K Inoue et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2003)
Probiotic bacteria in the management of atopic disease: Underscoring the importance of viability
PV Kirjavainen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates
F Canducci et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children
N Simakachorn et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2000)